The 45th DIA Annual Meeting

The DIA Annual Meeting is the "event to attend" each year for biotechnology, pharmaceutical, and regulatory professionals.  No other industry meeting of its kind can rival the breadth and depth of experience that this meeting delivers, with 26 content-area tracks and over 300 sessions, and presentations geared to attendees of all experience levels.  The DIA Annual Meeting, above all others, offers valuable professional cross-functional learning, networking experiences, and continuing education credits for attending tutorials and sessions.

Learning Objectives:

At the conclusion of this meeting, participants should be able to:

·          Describe the current regulatory and public policy environment pertaining to pharmaceuticals with an emphasis on the Food and Drug Administration;

·          Discuss the international regulations and economic factors that impact the global biopharmaceutical industry;

·          Recognize the challenges facing the FDA and the pharmaceutical industry in areas such as research study design and statistical methodology;

·          Recognize the state of the art clinical and statistical systems and implementations;

·          Recognize the written and communications skills needed to promote your career and your company’s objectives;

·          Enhance your working relationship with colleagues, both locally and internationally;

·          Describe legal, advertising, and marketing issues related to providing product information;

·          Discuss statistics, economics, and quality of life science;

·          Enhance your knowledge of risk assessment and management in the areas such as computer systems validation and drug safety and pharmacovigilance;

Nancy L. Snyderman, MD

Chief Medical Editor,

NBC News